SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-14-007510
Filing Date
2014-02-18
Accepted
2014-02-18 21:16:11
Documents
2
Period of Report
2014-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 L. DRAPEAU rrd402544.html 3  
1 FORM 3 L. DRAPEAU rrd402544.xml 3 2949
2 POWER OF ATTORNEY rrd362286_410456.htm EX-24.TXT 4557
  Complete submission text file 0001181431-14-007510.txt   9040
Mailing Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060
Business Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060 650-888-2422
AmpliPhi Biosciences Corp (Issuer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 371 BEL MARIN KEYS BLVD., SUITE 210 NOVATO CA 94949
Business Address
DRAPEAU LOUIS (Reporting) CIK: 0001248091 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23930 | Film No.: 14623821